Selegiline and Parkinson??s Disease
Authors:
- 1 May 1990
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 39 (5) , 646-651
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Selegiline Use to Prevent Progression of Parkinson's DiseaseArchives of Neurology, 1989
- DATATOP: A Multicenter Controlled Clinical Trial in Early Parkinson's DiseaseArchives of Neurology, 1989
- Platelet monoamine oxidase in Parkinson patients: effect of L-deprenyl therapyJournal of Neural Transmission, 1989
- Experience with selegiline in the treatment of Parkinson's disease.1987
- Deprenyl (selegiline) combined with levodopa and a decarboxylase inhibitor in the treatment of Parkinson's diseaseActa Neurologica Scandinavica, 1983
- Treatment of Parkinson's disease in early and late phases. Use of pharmacological agents with special reference to deprenyl (selegiline)Acta Neurologica Scandinavica, 1983
- (-)Deprenyl in the Treatment of Parkinsonʼs DiseaseClinical Neuropharmacology, 1982
- SELECTIVE ACETYLENIC ‘SUICIDE’ AND REVERSIBLE INHIBITORS OF MONOAMINE OXIDASE TYPES A AND BBritish Journal of Pharmacology, 1981
- Recent observations on the clinical pharmacology of (-)deprenylJournal of Neural Transmission, 1978
- Overview of present day treatment of Parkinson's diseaseJournal of Neural Transmission, 1978